Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stryker CEO Kevin Lobo Is Incoming Chair At AdvaMed

Executive Summary

AdvaMed's next board chair will be Stryker CEO Kevin Lobo, who will fill the leadership role beginning next March, when current chair Nadim Yared's two-year tenure is over. Lobo pledged to to work to improve diversity in industry.

You may also be interested in...



Diversity, More Advocacy Among Lobo’s Top Priorities As New AdvaMed Board Chair

Stryker CEO Kevin Lobo says while repeal of the medical device tax is his top issue, there are four main priorities he wants to work on over the next two years as industry advocate group AdvaMed’s board chair. They include better public engagement, increased advocacy work with the new Congress, advancing new technology – especially start-ups – and increasing diversity in the medtech industry.

Filling The Device Sector's Diversity Gap: MedTech Color Builds Support

MedTech Color is focused on enhancing diversity in the device and diagnostics space and increasing thought leadership opportunities for people of color in the industry. The organization held a launch event at this year's MedTech Conference in Philadelphia, where Medtech Insight caught up with founder Kwame Ulmer.

A Helping Hand: 'MedTech Color' Aims To Move Minorities From Shop Floor To Executive Suite

Industry veteran Kwame Ulmer has cobbled together a new group to help address perceived racial disparities at device firms. "MedTech Color" has already attracted attention from heavy-hitters Johnson & Johnson, Medtronic, 3M and Danaher, as well as industry advocacy group AdvaMed.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT123366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel